Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ETELOS, INC. (ETLO)
|
Add to portfolio |
|
|
|
| Price: |
$0.65
| | Metrics |
| OS: |
24.1
|
M
| |
|
|
| Market cap: |
$15.6
|
M
| |
|
|
|
Net debt:
|
$1.57
|
M
| |
|
|
|
EV:
|
$17.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($4.3)
|
M
| |
|
|
|
EBIT
|
($4.0)
|
M
| |
|
|
| EPS |
($0.25)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Sep-30-05 | Dec-30-03 | Dec-31-02 | Dec-31-01 |
| Revenues | 0.2 | 0.1 | 0.3 | 0.3 | 10.8 | 13.9 | 16.2 | 13.5 |
| Revenue growth | 22.0% | -59.5% | -3.8% | | | -14.4% | 19.8% | 45.6% |
| Cost of goods sold | 0.3 | 0.5 | 0.3 | 0.1 | 5.3 | 9.5 | 18.5 | 11.9 |
| Gross profit | -0.1 | -0.4 | 0.0 | 0.2 | 5.5 | 4.4 | -2.3 | 1.6 |
| Gross margin | -78.7% | -340.7% | -3.6% | 58.9% | 50.9% | 31.8% | -14.0% | 11.8% |
| Selling, general and administrative | | | | | 8.6 | 4.5 | 5.6 | 8.7 |
| Sales and marketing | 0.8 | 1.7 | 0.8 | 0.3 | | | | |
| Research and development | 1.3 | 2.6 | 2.0 | 0.8 | 7.4 | 6.9 | 11.7 | 19.9 |
| General and administrative | 3.1 | 3.2 | 0.9 | 0.4 | | | | |
| EBIT | -5.0 | -21.3 | -3.7 | -1.3 | -10.5 | -7.2 | -19.5 | -27.0 |
| EBIT margin | -3348.0% | -17336.6% | -1217.1% | -425.6% | -97.8% | -52.1% | -120.0% | -199.3% |
| Pre-tax income | -6.8 | -19.3 | -4.0 | -1.5 | -10.0 | -7.2 | -19.3 | -27.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -6.8 | -19.3 | 0.0 | -1.5 | -10.0 | -7.2 | -19.3 | -27.0 |
| Net margin | -4501.3% | -15729.3% | -1.3% | -462.7% | -92.7% | -51.9% | -119.0% | -199.3% |
| |
| Diluted EPS | ($0.29) | ($1.06) | ($0.73) | ($0.14) | ($0.19) | ($0.17) | ($497.49) | ($1.00) |
| Shares outstanding (diluted) | 22.9 | 18.2 | 0.0 | 10.5 | 53.2 | 42.0 | 0.0 | 27.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|